ECM
GILD icon

Eisler Capital Management’s Gilead Sciences GILD Stock Holding History

Eisler Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.09M Sell
9,700
-200
-2% -$22.7K ﹤0.01% 557
2025
Q2 		$1.1M Sell
9,900
-40,500
-80% -$4.31M 0.01% 615
2025
Q1 		$5.64M Sell
50,400
-3,500
-6% -$361K 0.04% 428
2024
Q4 		$4.95M Buy
+53,900
New +$4.85M 0.02% 439

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Eisler Capital Management's GILD Position: Q3 2025 in Review

Eisler Capital Management reduced its Gilead Sciences (GILD) stake by 26% in Q3 2025, selling an estimated $94.8K and leaving 2,375 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #705.

Eisler Capital Management first reported a position in GILD in Q4 2024 and has held it in 4 quarters since. The position peaked at $559K in Q4 2024. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Eisler Capital Management held 2,375 shares of Gilead Sciences worth $267K as of Q3 2025.
  • Eisler Capital Management sold 834 Gilead Sciences shares in Q3 2025, an estimated $94.8K.
  • Gilead Sciences made up ﹤0.01% of Eisler Capital Management's portfolio in Q3 2025, its #705 holding.
  • Eisler Capital Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 4 quarters since.
  • Eisler Capital Management's Gilead Sciences position peaked at $559K in Q4 2024.
  • 2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.